aurelie terrier-lenglet

Publications

Article dans une revue (50)

A multidisciplinary meeting for generating a personalized pharmaceutical plan for older adults at hospital discharge: the IATROPREV study Chloé Cornille,Aurélie Lenglet,Bertrand Decaudin,François Puisieux,Lisa Mondetet al. British Journal of Clinical Pharmacology, 2025, ⟨10.1002/bcp.70098⟩ Article dans une revue hal-05094067v1
Prix de thèse de pharmacie clinique 2024 de l’Association nationale des enseignants de pharmacie clinique Aurélie Terrier-Lenglet,Pierrick Bedouch Le Pharmacien Clinicien, 2025, ⟨10.1016/j.phacli.2025.07.004⟩ Article dans une revue hal-05218227v1
Medication review in older adults at hospital discharge: an analysis of data from the IATROPREV study Chloé Cornille,Jean-Baptiste Beuscart,Bertrand Décaudin,François Puisieux,Roxane Giraultet al. European Geriatric Medicine, 2025, ⟨10.1007/s41999-025-01381-y⟩ Article dans une revue hal-05425376v1
Cartographie française des activités de pharmacie clinique réalisées auprès des patients âgés atteints de cancer : une enquête SFPO-SFPC Chloé Herledan,Anne Toulemonde,Mathilde Sturmia,Anne-Laure Clairet,Aurélie Terrier-Lengletet al. Bulletin du Cancer, 2025, 112 (5), pp.495-504. ⟨10.1016/j.bulcan.2024.12.017⟩ Article dans une revue hal-05054527v1
Le pharmacien clinicien dans l’hôpital de jour d’insuffisance cardiaque : quel impact ? D. Calvez,E. Vermes,A. Terrier-Lenglet,C. Debanne Le Pharmacien Clinicien, 2024, 59 (2), pp.e148. ⟨10.1016/j.phacli.2024.04.256⟩ Article dans une revue hal-04610570v1
Drugs adherence after hospitalisation for heart failure: what have we learned from a French survey ? Emmanuelle Vermes,aurelie terrier-lenglet,Maxime Doublet,Richard Isnard,François Roubilleet al. European Journal of Heart Failure, 2024, 26 (Supplement 2), pp.377 Article dans une revue hal-04804776v1
Can the integration of new rules into a clinical decision support system reduce the incidence of acute kidney injury and hyperkalemia among hospitalized older adults: a protocol for a stepped-wedge, cluster-randomized trial (DETECT-IP) Anaïs Payen,Nour Elhouda Tlili,Etienne Cousein,Laurie Ferret,Antoine Le Bozecet al. Trials, 2024, 25 (1), pp.779. ⟨10.1186/s13063-024-08569-w⟩ Article dans une revue hal-04797705v1
Prise en charge médicamenteuse de l’insuffisance cardiaque Syriane Bouras,Charlotte Debanne,Sophie Membre,Seyhan Denev,Aurélie Terrier Le Pharmacien Clinicien, 2023, ⟨10.1016/j.phacli.2023.07.004⟩ Article dans une revue hal-04192616v1
Comparison of homocitrulline and carbamylated albumin as biomarkers of carbamylation reactions in hemodialyzed patients Aurelie Lenglet,Stéphane Jaisson,Philippe Gillery,Souleiman El Balkhi,Sophie Liabeufet al. Amino Acids, 2023, 55 (10), pp.1455-1460. ⟨10.1007/s00726-023-03306-0⟩ Article dans une revue hal-04176949v1
Audit croisé des activités de pharmacie clinique entre deux centres hospitalo-universitaires : retour d’expérience d’une démarche stimulante Thierry Nai,Marion Fourtage,Anne Feron,Mohammed Belhout,Hugues Bourgeoiset al. Le Pharmacien Clinicien, 2023, ⟨10.1016/j.phacli.2023.07.003⟩ Article dans une revue hal-04182891v1
Effectiveness and safety of apixaban and rivaroxaban vs warfarin in patients with atrial fibrillation and chronic kidney disease Sylvie Perreault,Laurie-Anne Boivin Proulx,Aurélie Lenglet,Ziad Massy,Marc Dorais World Journal of Nephrology, 2023, 12 (5), pp.132-146. ⟨10.5527/wjn.v12.i5.132⟩ Article dans une revue hal-04496436v1
Effectiveness and safety of low-dose versus standard-dose rivaroxaban and apixaban in patients with atrial fibrillation Sylvie Perreault,Robert Côté,Alice Dragomir,Brian White-Guay,Aurélie Lengletet al. PLoS ONE, 2022, 17 (12), pp.e0277744. ⟨10.1371/journal.pone.0277744⟩ Article dans une revue hal-03890259v1
Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial Fibrillation Sylvie Perreault,Alice Dragomir,Robert Cote,Aurelie Lenglet,Simon De Denuset al. Frontiers in Pharmacology, 2022, 12, ⟨10.3389/fphar.2021.812018⟩ Article dans une revue hal-03566157v1
Iatrogeny in the elderly: assessment of pharmaceutical interventions in a cardiology department S. Bouras,Aurélie Terrier-Lenglet,M. Belhout,C. Debanne International Journal of Clinical Pharmacy, 2022, 44 (6), pp.1536-1537 ; PP105 Article dans une revue hal-04031745v1
Drugs at risk: assessing pharmacy and medical interns' knowledge of injectable antidiabetics S. Bouras,Aurélie Terrier-Lenglet,M. Belhout,C. Debanne International Journal of Clinical Pharmacy, 2022, 44 (6), pp.1536-1537 ; PP106 Article dans une revue hal-04031740v1
Trends of use and factors that determine the choice of oral anticoagulants in women and men with atrial fibrillation Aurélie Lenglet,Jakub Qazi,Laurie‐anne Boivin Proulx,Catherine Legault,Marc Doraiset al. Pharmacology Research & Perspectives, 2022, 10 (6), ⟨10.1002/prp2.1012⟩ Article dans une revue hal-03870121v1
Acceptance Factors for In-Hospital Pharmacist Interventions in Daily Practice: A Retrospective Study Amaury Durand,André Gillibert,Sophie Membre,Lisa Mondet,Aurélie Lengletet al. Frontiers in Pharmacology, 2022, 13, ⟨10.3389/fphar.2022.811289⟩ Article dans une revue hal-04139786v1
Influence of the implementation of a multidisciplinary consultation program on adherence to the first ever course of oral antineoplastic treatment in patients with cancer Aurelie Feral,Mathieu Boone,Virginie Lucas,Céline Bihan,Mohamed Belhoutet al. Journal of Oncology Pharmacy Practice, 2021, 28 (7), pp.1543-1551. ⟨10.1177/10781552211035368⟩ Article dans une revue hal-03792480v1
Comparative effectiveness and safety of low versus high dose rivaroxaban and apixaban for atrial fibrillation: A propensity score-matched cohort study Sylvie Perreault,Alice Dragomir,Robert Cote,Brian White-Guay,Aurélie Lengletet al. Pharmacoepidemiology and Drug Safety, 2021, 30 (1, SI), pp.176-177 Article dans une revue hal-04139787v1
Comparative effectiveness and safety of high-dose rivaroxaban and apixaban for atrial fibrillation: A propensity score-matched cohort study Sylvie Perreault,Alice Dragomir,Robert Cote,Aurelie Lenglet,Brian White-Guayet al. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2021, 41 (4), pp.379-393. ⟨10.1002/phar.2509⟩ Article dans une revue hal-03584692v1
Effect of Sevelamer and Nicotinamide on Albumin Carbamylation in Patients with End-Stage Kidney Disease Aurélie Lenglet,Mohamad Ali Rahali,François Ludovic Sauvage,Sophie Liabeuf,Gabriel Choukrounet al. Drugs in R&D, 2021, 21 (2), pp.231-238. ⟨10.1007/s40268-021-00350-7⟩ Article dans une revue hal-03287335v1
Using of pharmaceutical intelligence in a new software to improve pharmaceutical analysis of anticoagulants S. Membre,C. Mabille,L. Mondet,M. Belhout,Aurélie Terrier-Lengletet al. International Journal of Clinical Pharmacy, 2019, 41 (5), pp.1388-1389 Article dans une revue hal-03584688v1
Randomised, open label multicentre, non-inferiority clinical trial for new treat modalities for cutaneous leishmaniasis caused by leishmania tropica S. Kamink,Aurélie Lenglet,T. Pylypenko,T. Jensen,S. Ashrafet al. Transactions of The Royal Society of Tropical Medicine and Hygiene, 2019, 113 (1, SI), pp.S157 Article dans une revue hal-04139790v1
Noma prevalence study, Northwest Nigeria 2018 E. Farley,O. J. Modupe,J. Schuurmans,F. Saleh,C. Ihekweazuet al. Transactions of The Royal Society of Tropical Medicine and Hygiene, 2019, 113 (1, SI), pp.S68-S69 Article dans une revue hal-04139788v1
Risk factors for diagnosed noma in northwest Nigeria: a case-control study E. Farley,Aurélie Lenglet,C. Ariti,N. M. Jiya,A. S. Adetunjiet al. Transactions of The Royal Society of Tropical Medicine and Hygiene, 2019, 113 (1, SI), pp.S227-S228 Article dans une revue hal-04139789v1
Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients? Aurelie Lenglet,Nicolas Fabresse,Meline Taupin,Cathy Gomila,Sophie Liabeufet al. Drugs, 2019, 79 (8), pp.855-862. ⟨10.1007/s40265-019-01118-9⟩ Article dans une revue hal-03578810v1
CONSIGNELA: A multidisciplinary patient-centered project to improve drug prescription comprehension and execution in elderly people and parkinsonian patients Gregory Moro Puppi Wanderley,Élodie Vandenbergh,Marie-Hélène Abel,Jean-Paul Barthès,Mathieu Hainselinet al. Telematics and Informatics, 2018, 35 (4), pp.913-929. ⟨10.1016/j.tele.2017.11.010⟩ Article dans une revue hal-01661708v1
Détermination des caractéristiques des erreurs médicamenteuses détectées par la conciliation médicamenteuse en rhumatologie Amélie Boursier,Aurélien Mary,Franck Grados,Isabelle Desailly Henry,Aurélie Terrier Lengletet al. Revue du Rhumatisme, 2018, 85 (3), pp.285-290. ⟨10.1016/j.rhum.2017.02.004⟩ Article dans une revue hal-03859610v1
Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients Aurelien Mary,Agnes Hartemann,Sophie Liabeuf,Carole Elodie Aubert,Salim Kemelet al. Cardiovascular Diabetology, 2017, 16, ⟨10.1186/s12933-017-0509-7⟩ Article dans une revue hal-03555488v1
Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study (vol 32, pg 870, 2017) Aurelie Lenglet,Sophie Liabeuf,Najeh El Esper,Sandrine Brisset,Janette Mansouret al. Nephrology Dialysis Transplantation, 2017, 32 (9), pp.1597. ⟨10.1093/ndt/gfx249⟩ Article dans une revue hal-03564975v1
Assessment of clinical practice: drug's prescriptions in hospitalized patients aged 75 years and older L. Mondet,B. Marquant,I. Defouilloy,Aurélie Terrier-Lenglet,M. Belhoutet al. Fundamental & Clinical Pharmacology, 2017, 31 (1, SI), pp.12 Article dans une revue hal-03584689v1
Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study Aurelie Lenglet,Sophie Liabeuf,Najeh El Esper,Sandrine Brisset,Janette Mansouret al. Nephrology Dialysis Transplantation, 2017, 32 (5), pp.870-879. ⟨10.1093/ndt/gfw042⟩ Article dans une revue hal-03564976v1
Clinical impact of medication reconciliation at admission in a cardiac surgery unit Mathilde Royer,Benjamin Valentin,Y. Hun,Joseph Nader,Thierry Causet al. International Journal of Clinical Pharmacy, 2017, 39 (1), pp.244-245 Article dans une revue hal-03572342v1
The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells Pauline Estupina,Alexandre Fontayne,Jean-Marc Barret,Nathalie Kersual,Olivier Dubreuilet al. Oncotarget, 2017, 8 (23), pp.37061-37079. ⟨10.18632/oncotarget.15715⟩ Article dans une revue hal-02379710v1
N-methyl-2-pyridone-5-carboxamide (2PY)-Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin Aurelie Lenglet,Sophie Liabeuf,Sandra Bodeau,Loïc Louvet,Aurelien Maryet al. Toxins, 2016, 8 (11), ⟨10.3390/toxins8110339⟩ Article dans une revue hal-03568256v1
The clinical impact of treatment discrepancies recorded for 200 patients in an acute geriatric unit P. Saint-Germain,M. Ruelle,Aurélien Mary,S. Sid Idris,S. Hannatet al. La Revue de Médecine Interne, 2016, 37 (10), pp.667-673. ⟨10.1016/j.revmed.2016.02.017⟩ Article dans une revue hal-03584690v1
Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients Aurélie Lenglet,Sophie Liabeuf,Pauline Guffroy,Albert Fournier,Michel Brazieret al. Drugs in R&D, 2013, 13 (3), pp.165-173. ⟨10.1007/s40268-013-0024-6⟩ Article dans une revue hal-04139792v1
Association between Free Light Chain Levels, and Disease Progression and Mortality in Chronic Kidney Disease Lucie Desjardins,Sophie Liabeuf,Aurélie Lenglet,Horst-Dieter Lemke,Raymond Vanholderet al. Toxins, 2013, 5 (11), pp.2058-2073. ⟨10.3390/toxins5112058⟩ Article dans une revue hal-04139791v1
The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients Rodrigo Bueno De Oliveira,Sophie Liabeuf,Hirokazu Okazaki,Aurélie Lenglet,Lucie Desjardinset al. Clinical Kidney Journal, 2013, 6 (1), pp.63-70. ⟨10.1093/ckj/sfs176⟩ Article dans une revue hal-04139795v1
The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients Rodrigo B. De Oliveira,Sophie Liabeuf,Hirokazu Okazaki,Aurélie Lenglet,Lucie Desjardinset al. Nephrology Dialysis Transplantation, 2013, 28 (1), pp.165 Article dans une revue hal-04139794v1
Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins? Sophie Liabeuf,Griet Glorieux,Aurélie Lenglet,Momar Diouf,Eva Scheperset al. PLoS ONE, 2013, 8 (6), ⟨10.1371/journal.pone.0067168⟩ Article dans une revue hal-04139793v1
FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages L. Desjardins,S. Liabeuf,C. Renard,Aurélie Lenglet,H-D. Lemkeet al. Osteoporosis International, 2012, 23 (7), pp.2017-2025. ⟨10.1007/s00198-011-1838-0⟩ Article dans une revue istex hal-04139799v1
Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease Nathalie Neirynck,Sunny Eloot,Griet Glorieux,Daniela V. Barreto,Fellype C. Barretoet al. PLoS ONE, 2012, 7 (8), ⟨10.1371/journal.pone.0044201⟩ Article dans une revue hal-04139798v1
Misuse of a Salbutamol Inhaler Causing Skin Burns Aurélie Terrier-Lenglet,Houcine Chaib Derra,Catherine Devoldere,Valérie Dufour,Valerie Graset al. Therapies, 2012, 67 (1), pp.59-61. ⟨10.2515/therapie/2012008⟩ Article dans une revue istex hal-04139713v1
Prognostic implications of plasma myoglobin levels in patients with chronic kidney disease Aurélie Lenglet,Sophie Liabeuf,Lucie Desjardins,Nathalie Neirynck,Griet Glorieuxet al. The International Journal of Artificial Organs, 2012, 35 (11), pp.959-968. ⟨10.5301/ijao.5000124⟩ Article dans une revue hal-04139797v1
Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients Sophie Liabeuf,Aurélie Lenglet,Lucie Desjardins,Nathalie Neirynck,Griet Glorieuxet al. Kidney International, 2012, 82 (12), pp.1297-1303. ⟨10.1038/ki.2012.301⟩ Article dans une revue hal-04139796v1
Plasma malondialdehyde may not predict mortality in patient with chronic kidney disease Aurélie Terrier-Lenglet,Aude Nollet,Sophie Liabeuf,Daniela V. Barreto,Michel Brazieret al. Néphrologie & Thérapeutique, 2011, 7 (4), pp.219-224. ⟨10.1016/j.nephro.2010.12.009⟩ Article dans une revue istex hal-04139714v1
Prognostic Implication of Plasma Osteopontin Levels in Patients with Chronic Kidney Disease Daniela V. Barreto,Aurélie Lenglet,Sophie Liabeuf,Axel Kretschmer,Fellype C. Barretoet al. Nephron Clinical Practice, 2011, 117 (4), pp.C363-C372. ⟨10.1159/000321520⟩ Article dans une revue hal-04139800v1
Pathological gambling and dopaminergic agonists Aurélie Lenglet,V. Gras,A. Smail,P. Krystkowiak,I. Bonnetet al. Fundamental & Clinical Pharmacology, 2009, 23, pp.39 Article dans une revue hal-04139801v1
Optimization of the treatment after stroke attack in the rehabilitation center: place of the pharmacist in a multidisciplinary team Aurélie Lenglet,L. Lenne,L. Leteurtre,S. Bakhtaoui-Couriat,F. Perlaet al. Pharmacy World and Science, 2009, 31 (2), pp.308 Article dans une revue hal-04139802v1

Ouvrages (1)

Pharmacie clinique et dispositifs médicaux Pierre Albaladejo,Rémi Achin,Benoît Allenet,Rémi Alvo,Isabelle Adenotet al. Elsevier, 2023, 978-2-294-77399-0. ⟨10.1016/C2020-0-02746-5⟩ Ouvrages hal-04131398v1